Here are four key notes:
1. The agreement includes DenerveX System distribution in Italy.
2. Via the agreement, AlfaMed will provide sales, marketing and distribution services for the DenerveX System launch.
3. The DenerveX System includes the DenerveX device and the DenerveX Pro-40 Power Generator. The system is intended to relieve pain associated with the facet joint.
4. Currently, the DenerveX is not FDA cleared or CE marked.
More articles on devices:
How consolidation, bundled payments and standardization shape the medical device field: Key thoughts from Johnson & Johnson Medical Devices Companies’ Tim Schmid
Global 3-D printed medical devices market to grow at CAGR of 17.7% through 2026: 6 observations
Spinal Simplicity brings patent count to 52 — 5 highlights
